| Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors K Lechner, C von Schacky, AL McKenzie, N Worm, U Nixdorff, B Lechner, ... European journal of preventive cardiology 27 (4), 394-406, 2020 | 269 | 2020 |
| A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: a randomized, controlled trial C Bamberger, A Rossmeier, K Lechner, L Wu, E Waldmann, S Fischer, ... Nutrients 10 (2), 244, 2018 | 123 | 2018 |
| High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation K Lechner, AL McKenzie, N Kränkel, C Von Schacky, N Worm, U Nixdorff, ... Metabolic syndrome and related disorders 18 (4), 176-185, 2020 | 111 | 2020 |
| Inflammation and cardiovascular disease: the future N Arnold, K Lechner, C Waldeyer, MD Shapiro, W Koenig European Cardiology Review 16, 2021 | 72 | 2021 |
| A walnut-enriched diet reduces lipids in healthy Caucasian subjects, independent of recommended macronutrient replacement and time point of consumption: a prospective … C Bamberger, A Rossmeier, K Lechner, L Wu, E Waldmann, RG Stark, ... Nutrients 9 (10), 1097, 2017 | 64 | 2017 |
| Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes SJ Athinarayanan, SJ Hallberg, AL McKenzie, K Lechner, S King, ... Cardiovascular diabetology 19, 1-13, 2020 | 59 | 2020 |
| Circulating nucleosomes as potential markers to monitor COVID-19 disease progression E Cavalier, J Guiot, K Lechner, A Dutsch, M Eccleston, M Herzog, T Bygott, ... Frontiers in Molecular Biosciences 8, 600881, 2021 | 36 | 2021 |
| Therapy of endocrine disease: medical treatment of primary aldosteronism B Lechner, K Lechner, D Heinrich, C Adolf, F Holler, H Schneider, ... European Journal of Endocrinology 181 (4), R147-R153, 2019 | 31 | 2019 |
| Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance K Lechner, B Lechner, A Crispin, PEH Schwarz, H von Bibra Scientific Reports 11 (1), 8224, 2021 | 27 | 2021 |
| The effect of exercise intensity and volume on metabolic phenotype in patients with metabolic syndrome: a randomized controlled trial P Von Korn, S Keating, S Mueller, B Haller, N Kraenkel, S Dinges, ... Metabolic syndrome and related disorders 19 (2), 107-114, 2021 | 16 | 2021 |
| Are atherogenic lipoprotein phenotype and inflammation indicative of plaque phenotype and clinical stability in coronary artery disease?—Reply R Vergallo, I Porto, F Crea JAMA cardiology 4 (9), 951-952, 2019 | 14 | 2019 |
| Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: The Aldo-DHF randomized controlled trial K Lechner, J Scherr, E Lorenz, B Lechner, B Haller, A Krannich, M Halle, ... Clinical Research in Cardiology, 1-14, 2022 | 13 | 2022 |
| Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men JM Hennings, S Heel, K Lechner, M Uhr, T Dose, L Schaaf, F Holsboer, ... JCI insight 4 (1), 2019 | 12 | 2019 |
| Recommendations on sodium intake for cardiovascular health: conviction or evidence? K Lechner, H Schunkert European Heart Journal 41 (35), 3374-3375, 2020 | 9 | 2020 |
| Hydrothermally modified slow release corn starch: a potential new therapeutic option for treating hypoglycemia in autoimmune hypoglycemia (Hirata’s disease) K Lechner, B Aulinger, S Brand, E Waldmann, KG Parhofer European Journal of Clinical Nutrition 69 (12), 1369-1370, 2015 | 9 | 2015 |
| Obesity and cardiovascular disease: beyond body weight and energy balance K Lechner, RM Krauss European Journal of Preventive Cardiology 29 (17), 2216-2217, 2022 | 8 | 2022 |
| Should we use genetic scores in the determination of treatment strategies to control dyslipidemias? K Lechner, T Kessler, H Schunkert Current Cardiology Reports 22, 1-9, 2020 | 8 | 2020 |
| Exercise recommendations in athletes with coronary artery calcification K Lechner, M Halle, J Scherr, JA Drezner European journal of preventive cardiology 27 (8), 882-884, 2020 | 8 | 2020 |
| The ‘heart’of preventive cardiology: lifestyle medicine for the treatment of cardiometabolic diseases K Lechner, E Lorenz, JA Drezner European Journal of Preventive Cardiology 27 (19), 2069-2070, 2020 | 6 | 2020 |
| Saturated fatty acid blood levels and cardiometabolic phenotype in patients with HFpEF: a secondary analysis of the Aldo-DHF trial K Lechner, C von Schacky, J Scherr, E Lorenz, M Bock, B Lechner, ... Biomedicines 10 (9), 2296, 2022 | 5 | 2022 |
Johannes Scherr在 balgrist.ch 的电子邮件经过验证
